These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 31595847)

  • 1. Controlled Delivery of Nitric Oxide for Cancer Therapy.
    Alimoradi H; Greish K; Gamble AB; Giles GI
    Pharm Nanotechnol; 2019; 7(4):279-303. PubMed ID: 31595847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric Oxide-Releasing Biomaterials for Biomedical Applications.
    Zhou X; Zhang J; Feng G; Shen J; Kong D; Zhao Q
    Curr Med Chem; 2016; 23(24):2579-2601. PubMed ID: 27480214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide releasing nanomaterials for cancer treatment: current status and perspectives.
    Seabra AB; de Lima R; Calderón M
    Curr Top Med Chem; 2015; 15(4):298-308. PubMed ID: 25579351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects.
    Huang Z; Fu J; Zhang Y
    J Med Chem; 2017 Sep; 60(18):7617-7635. PubMed ID: 28505442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances on the development of NO-releasing molecules (NORMs) for biomedical applications.
    Bhowmik R; Roy M
    Eur J Med Chem; 2024 Mar; 268():116217. PubMed ID: 38367491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-donating materials and their potential in pharmacological applications for site-specific nitric oxide delivery.
    Eroy-Reveles AA; Mascharak PK
    Future Med Chem; 2009 Nov; 1(8):1497-507. PubMed ID: 21426062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001.
    Scicinski J; Oronsky B; Ning S; Knox S; Peehl D; Kim MM; Langecker P; Fanger G
    Redox Biol; 2015 Dec; 6():1-8. PubMed ID: 26164533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric Oxide and Tumors: From Small-Molecule Donor to Combination Therapy.
    Huang W; Zhang J; Luo L; Yu Y; Sun T
    ACS Biomater Sci Eng; 2023 Jan; 9(1):139-152. PubMed ID: 36576226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric Oxide: Physiological Functions, Delivery, and Biomedical Applications.
    Andrabi SM; Sharma NS; Karan A; Shahriar SMS; Cordon B; Ma B; Xie J
    Adv Sci (Weinh); 2023 Oct; 10(30):e2303259. PubMed ID: 37632708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Design and Medicinal Applications of Nano-Nitric Oxide Delivery Systems.
    Nguyen KT; Wu Z; Huang T; Tay CY
    Curr Med Chem; 2018; 25(12):1420-1432. PubMed ID: 28403790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide-releasing biomaterials for promoting wound healing in impaired diabetic wounds: State of the art and recent trends.
    Ahmed R; Augustine R; Chaudhry M; Akhtar UA; Zahid AA; Tariq M; Falahati M; Ahmad IS; Hasan A
    Biomed Pharmacother; 2022 May; 149():112707. PubMed ID: 35303565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyotosol-selective nitric oxide bomb as a new paradigm of an anticancer drug.
    Park D; Im S; Saravanakumar G; Lee YM; Kim J; Kim K; Lee J; Kim J; Kim WJ
    Chem Commun (Camb); 2019 Dec; 55(98):14789-14792. PubMed ID: 31761922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the study of nitric oxide-donating drugs].
    Zhang YH; Peng SX
    Yao Xue Xue Bao; 2009 Nov; 44(11):1200-10. PubMed ID: 21355319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hollow S-nitrosothiols nanoparticle with polymeric brushes for nitric oxide (NO)-releasing as tumor targeted chemotherapy.
    Wang J; Bi Y; Ruan H; Sun G; Cui X; Yang X; Qin C
    J Biomater Sci Polym Ed; 2019 Feb; 30(2):122-136. PubMed ID: 30522414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local delivery of nitric oxide: targeted delivery of therapeutics to bone and connective tissues.
    Nichols SP; Storm WL; Koh A; Schoenfisch MH
    Adv Drug Deliv Rev; 2012 Sep; 64(12):1177-88. PubMed ID: 22433782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide donors for prostate and bladder cancers: Current state and challenges.
    Seabra AB; Durán N
    Eur J Pharmacol; 2018 May; 826():158-168. PubMed ID: 29501865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors: chemical activities and biological applications.
    Wang PG; Xian M; Tang X; Wu X; Wen Z; Cai T; Janczuk AJ
    Chem Rev; 2002 Apr; 102(4):1091-134. PubMed ID: 11942788
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitric oxide in cancer therapeutics: interaction with cytotoxic chemotherapy.
    Hirst D; Robson T
    Curr Pharm Des; 2010; 16(4):411-20. PubMed ID: 20236069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications for nitric oxide in halting proliferation of tumor cells.
    Reynolds MM; Witzeling SD; Damodaran VB; Medeiros TN; Knodle RD; Edwards MA; Lookian PP; Brown MA
    Biochem Biophys Res Commun; 2013 Feb; 431(4):647-51. PubMed ID: 23337501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins.
    Safdar S; Taite LJ
    Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.